Issue 29, 2018, Issue in Progress

Use of novel haptens in the production of antibodies for the detection of tryptamines

Abstract

Tryptamines are a group of hallucinogenic drugs whose detection in body fluids could be simplified by immunochemical assay kits. Antibodies for these assays are obtained by the immunization of laboratory animals with conjugates of a hapten similar to the target analyte and a suitable protein. Therefore we synthesized novel haptens derived from tryptamine-based drugs, with N,N-dimethyltryptamine (DMT), 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) and N,N-diisopropyltryptamine (DiPT) selected as the target analytes. Their structures were modified with a short linker ended with a carboxylic group. The haptens were conjugated with bovine serum albumin (BSA) and rabbits were immunized with the conjugates. The obtained polyclonal antibodies showed good reactivity and the LOD of the constructed ELISAs was in the range 0.006–0.254 ng mL−1. Thus, they are suitable for the development of immunochemical assay kits.

Graphical abstract: Use of novel haptens in the production of antibodies for the detection of tryptamines

Supplementary files

Article information

Article type
Paper
Submitted
22 Mar 2018
Accepted
24 Apr 2018
First published
01 May 2018
This article is Open Access
Creative Commons BY license

RSC Adv., 2018,8, 16243-16250

Use of novel haptens in the production of antibodies for the detection of tryptamines

M. Maryška, L. Fojtíková, R. Jurok, B. Holubová, O. Lapčík and M. Kuchař, RSC Adv., 2018, 8, 16243 DOI: 10.1039/C8RA02528B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements